Intuitive Surgical, Inc. ( ISRG) Q4 2025 Earnings Call January 22, 2026 4:30 PM EST Daniel Connally - VP & Head of Investor ...

Medical negligence in Nigeria came to the fore when author Chimamanda Ngozi Adichie accused a Lagos hospital of negligence ...

ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings ...

Some medical errors are unreported or even unknown to patients. Only those that result in severe complications and death are ...

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, ...

Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...

Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew ...

If you are wondering whether Intuitive Surgical's share price still makes sense at current levels, the key question is how ...

This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital.

A surgical mistake by a Broward bariatric surgeon will cost him time and money — taking continuing medical education courses ...

Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid moat. Click for why I'm bullish on ISRG.

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, CMR Surgical (‘CMR’ or ‘the Company’), the global surgical robotics ...